Evidence map›Paper›PMID 30208386›Full record

ArticleJAMA surgery2018

Development and Validation of a Prediction Model for Mortality and Adverse Outcomes Among Patients With Peripheral Eosinopenia on Admission for Clostridium difficile Infection.

Audrey S Kulaylat, Erica L Buonomo, Kenneth W Scully, Christopher S Hollenbeak, Heather Cook, William A Petri, David B Stewart

Open access · bronzeAbstract readValidation Study
In one paragraph

Article in JAMA surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Gastro hep advances · 2026
    Article
  4. Review
  5. Article
  6. Severe and Rapid Progression ofRespirology case reports · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Derivation and internal validation of the multivariate toxigenicAntimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Article
  12. Host Immune Responses toTropical medicine and infectious disease · 2023
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Validation of Clinical Risk Models for Clostridioides difficileAntimicrobial agents and chemotherapy · 2022
    Article
  18. Article
  19. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Audrey S KulaylatDepartment of Surgery, Pennsylvania State University, College of Medicine, Hershey.
Erica L BuonomoDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville.
Kenneth W ScullyDepartment of Public Health Sciences, University of Virginia, Charlottesville.
Christopher S HollenbeakDepartment of Surgery, Pennsylvania State University, College of Medicine, Hershey.
Heather CookDepartment of Statistics, University of Virginia, Charlottesville.
William A PetriDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville.
David B StewartDepartment of Surgery, University of Arizona, Tucson.
Pennsylvania State University · USUniversity of Virginia · USUniversity of Virginia Health System · USUniversity of Arizona · US

Funding

Role of Type 2 Immunity in Innate Protection from C. difficileR01AI124214 · NIAID · UNIVERSITY OF VIRGINIA · PI William A Petri · 2016 to 2026
$5.4M
NIAID NIH HHS R01 AI124214
6 · The paper itself

Abstract

Importance: Recent evidence from an animal model suggests that peripheral loss of eosinophils in Clostridium difficile infection (CDI) is associated with severe disease. The ability to identify high-risk patients with CDI as early as the time of admission could improve outcomes by guiding management decisions. Objective: To construct a model using clinical indices readily available at the time of hospital admission, including peripheral eosinophil counts, to predict inpatient mortality in patients with CDI. Design, Setting, and Participants: In a cohort study, a total of 2065 patients admitted for CDI through the emergency department of 2 tertiary referral centers from January 1, 2005, to December 31, 2015, formed a training and a validation cohort. The sample was stratified by admission eosinophil count (0.0 cells/μL or >0.0 cells/μL), and multivariable logistic regression was used to construct a predictive model for inpatient mortality as well as other disease-related outcomes. Main Outcomes and Measures: Inpatient mortality was the primary outcome. Secondary outcomes included the need for a monitored care setting, need for vasopressors, and rates of inpatient colectomy. Results: Of the 2065 patients in the study, 1092 (52.9%) were women and patients had a mean (SD) age of 63.4 (18.4) years. Those with an undetectable eosinophil count at admission had increased in-hospital mortality in both the training (odds ratio [OR], 2.01; 95% CI, 1.08-3.73; P = .03) and validation (OR, 2.26; 95% CI, 1.33-3.83; P = .002) cohorts in both univariable and multivariable analysis. Undetectable eosinophil counts were also associated with indicators of severe sepsis, such as admission to monitored care settings (OR, 1.40; 95% CI, 1.06-1.86), the need for vasopressors (OR, 2.08; 95% CI, 1.32-3.28), and emergency total colectomy (OR, 2.56; 95% CI, 1.12-5.87). Other significant predictors of mortality at admission included increasing comorbidity burden (for each 1-unit increase: OR, 1.13; 95% CI, 1.05-1.22) and lower systolic blood pressures (for each 1-mm Hg increase: OR, 0.99; 95% CI, 0.98-1.00). In a subgroup analysis of patients presenting without initial tachycardia or hypotension, only patients with undetectable admission eosinophil counts, but not those with an elevated white blood cell count, had significantly increased odds of inpatient mortality (OR, 5.76; 95% CI, 1.99-16.64). Conclusions and Relevance: This study describes a simple, widely available, inexpensive model predicting CDI severity and mortality to identify at-risk patients at the time of admission.

Indexed as

AdultAgedClostridium InfectionsEosinophilsFemaleHumansLogistic ModelsMaleMiddle AgedModels, BiologicalOdds RatioPredictive Value of TestsRisk FactorsYoung Adult

Identifiers

PMID30208386
PMCPMC6414272
OpenAlexW2890919374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.